⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13677470 | 1.00 | — | — | |
| SCHEMBL7142371 | 0.84 | — | — | |
| SCHEMBL811643 | 0.84 | — | — | |
| SCHEMBL7137252 | 0.84 | — | — | |
| SCHEMBL11425937 | 0.82 | — | — | |
| SCHEMBL13185878 | 0.73 | — | — | |
| SCHEMBL5086014 | 0.72 | — | — | |
| SCHEMBL11038022 | 0.69 | MET (0.42) | — | |
| SCHEMBL11037992 | 0.69 | MET (0.42) | — | |
| SCHEMBL1068815 | 0.69 | LMNA (0.34) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025201533-A1 | NOVEL ACIDIC COMPOUNDS, COMPOSITIONS COMPRISING THE SAME AND USES THEREOF | NUPHASE THERAPEUTICS (SHANGHAI) LIMITED., CO. (CN) | 2025-10-02 | — | — | WO | disclosed |
| CN-118950103-A | Multilayer core-shell structure catalyst, preparation method and application thereof | 青岛科技大学 | 2024-11-15 | — | — | CN | disclosed |
| US-11840511-B2 | Haloacetaldehyde alkyl 2-cyclopentenyl acetal compound and a process for preparing the same, a process for preparing a (2-cyclopentenyl)acetate ester compound therefrom, and a process for preparing a (2-cyclopentenyl)acetic acid compound therefrom | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-12-12 | — | — | US | disclosed |
| US-11840511-B2 | Haloacetaldehyde alkyl 2-cyclopentenyl acetal compound and a process for preparing the same, a process for preparing a (2-cyclopentenyl)acetate ester compound therefrom, and a process for preparing a (2-cyclopentenyl)acetic acid compound therefrom | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-12-12 | — | — | US | disclosed |
| US-11840511-B2 | Haloacetaldehyde alkyl 2-cyclopentenyl acetal compound and a process for preparing the same, a process for preparing a (2-cyclopentenyl)acetate ester compound therefrom, and a process for preparing a (2-cyclopentenyl)acetic acid compound therefrom | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-12-12 | — | — | US | disclosed |
| EP-4101834-B1 | HALOACETALDEHYDE ALKYL 2-CYCLOPENTENYL ACETAL COMPOUND AND A PROCESS FOR PREPARING THE SAME, A PROCESS FOR PREPARING A (2-CYCLOPENTENYL)ACETATE ESTER COMPOUND THEREFROM, AND A PROCESS FOR PREPARING A (2-CYCLOPENTENYL)ACETIC ACID COMPOUND THEREFROM | SHINETSU CHEMICAL CO (JP) | 2023-11-22 | — | — | EP | disclosed |
| EP-4101834-B1 | HALOACETALDEHYDE ALKYL 2-CYCLOPENTENYL ACETAL COMPOUND AND A PROCESS FOR PREPARING THE SAME, A PROCESS FOR PREPARING A (2-CYCLOPENTENYL)ACETATE ESTER COMPOUND THEREFROM, AND A PROCESS FOR PREPARING A (2-CYCLOPENTENYL)ACETIC ACID COMPOUND THEREFROM | SHINETSU CHEMICAL CO (JP) | 2023-11-22 | — | — | EP | disclosed |
| WO-2023180976-A1 | INDAZOLES AS HEMATOPOIETIC PROGENITOR KINASE 1 (HPK1) INHIBITORS AND METHODS FOR USING SAME | 1ST Biotherapeutics, Inc. (KR) | 2023-09-28 | — | — | WO | disclosed |
| US-20230305396-A1 | Euv Photoresist With Low-Activation-Energy Ligands Or High-Developer-Solubility Ligands | TAIWAN SEMICONDUCTOR MANUFACTURING CO., LTD. (TW) | 2023-09-28 | — | — | US | disclosed |
| US-20230002304-A1 | HALOACETALDEHYDE ALKYL 2-CYCLOPENTENYL ACETAL COMPOUND AND A PROCESS FOR PREPARING THE SAME, A PROCESS FOR PREPARING A (2-CYCLOPENTENYL)ACETATE ESTER COMPOUND THEREFROM, AND A PROCESS FOR PREPARING A (2-CYCLOPENTENYL)ACETIC ACID COMPOUND THEREFROM | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-01-05 | — | — | US | disclosed |
| US-20080255239-A1 | SUBSTITUTED FLUOROETHYL UREAS AS ALPHA 2 ADRENERGIC AGENTS | ALLERGAN, INC. | 2008-10-16 | — | — | US | disclosed |
| US-20080194696-A1 | Novel Arylbicyclo[3.1.0]Hexylamines And Methods And Compositions For Their Preparation And Use | ETHISMOS RESEARCH, INC. | 2008-08-14 | — | — | US | disclosed |
| US-7348328-B2 | MCH antagonists for the treatment of obesity | SCHERING CORPORATION (US) | 2008-03-25 | — | — | US | disclosed |
| EP-1300381-B1 | Process for preparing optically active alcohols | JAPAN SCIENCE & TECH AGENCY (JP) | 2006-03-08 | — | — | EP | disclosed |
| US-6887820-B1 | For producing optically active secondary alcohols, producing optically active compounds useful for various utilities such as intermediates for synthesizing pharmaceutical agents, liquid crystal materials and agents for optical resolution | JAPAN SCIENCE AND TECHNOLOGY CORPORATION (JP) | 2005-05-03 | — | — | US | disclosed |
| EP-1300381-A1 | Process for preparing optically active alcohols | Japan Science and Technology Corporation (JP) | 2003-04-09 | — | — | EP | disclosed |
| US-6184381-B1 | USEFUL AS INTERMEDIATES FOR SYNTHESIZING PHARMACEUTICAL CHEMICALS, LIQUID CRYSTAL MATERIALS AND AGENTS FOR OPTICAL RESOLUTION, REDUCTION, KETONES TO ALCOHOL, IMINES TO AMINES | JAPAN SCIENCE & TECHNOLOGY CORP. (JP) | 2001-02-06 | — | — | US | disclosed |
| EP-0916637-A1 | PROCESS FOR PREPARATING OPTICALLY ACTIVE COMPOUNDS | Japan Science and Technology Corporation (JP) | 1999-05-19 | — | — | EP | disclosed |
| US-4219683-A | USING A PALLADIUM-THORIUM OXIDE CATALYST | PHILLIPS PETROLEUM COMPANY (US) | 1980-08-26 | — | — | US | disclosed |
| US-4058572-A | NICKEL CATALYSTS, STEREOSPECIFIC | SCM CORPORATION (US) | 1977-11-15 | — | — | US | disclosed |